Answer
It is licensed for high-risk non-metastatic castration-resistant prostate cancer and for metastatic hormone-sensitive prostate cancer in combination with androgen-deprivation therapy.
Sources for this answer
- Erleada 240 mg film coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.